2022 Update of the Korean Clinical Practice Guidelines for Stroke: Antithrombotic Therapy for Patients with Acute Ischemic Stroke or Transient Ischemic Attack

키워드

참고문헌 (39)

1. Chinese Acute Stroke Trial Collaborative Group, "CAST:randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke", Lancet, 349, pp.1641~1649 (1997)
2. International Stroke Trial Collaborative Group, "The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke", Lancet, 349, pp.1569~1581 (1997)
3. Chen ZM, "Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40 000 randomized patients from the Chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups", Stroke, 31, pp.1240~1249 (2000)
4. Wang Y, "Clopidogrel with aspirin in acute minor stroke or transient ischemic attack", N Engl J Med, 369, pp.11~19 (2013)
5. Johnston SC, "Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA", N Engl J Med, 379, pp.215~225 (2018)
6. Powers WJ, "Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association", American Stroke Association, 2019, pp.50, e344~H739
7. Boulanger JM, "Canadian stroke best practice recommendations for acute stroke management: prehospital, emergency department, and acute inpatient stroke care, 6th edition, update 2018", Int J Stroke, 13, pp.949~984 (2018)
8. "Clinical guidelines for stroke management. Chapter 3: Acute medical and surgical management" (2022)[URL]
9. Bath PM, "Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial", Lancet, 391, pp.850~859 (2018)
10. Johnston SC, "Ticagrelor versus aspirin in acute stroke or transient ischemic attack", N Engl J Med, 375, pp.35~43 (2016)
11. Powers WJ, "2018 Guidelines for the early management of patients with acute ischemic stroke : a guideline for healthcare professionals from the American Heart Association", American Stroke Association, 2018, pp.49, e46~e110
12. Klijn CJ, "Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation : a European Stroke Organisation guideline", Eur Stroke J, 4, pp.198~223 (2019)
13. Steffel J, "The 2018 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation", Eur Heart J, 39, pp.1330~1393 (2018)
14. The writing group of clinical practice guideline for stroke, "Clinical Practice Guideline for Stroke" (2009), Clinical Research Center for Stroke
15. United States Department of Health and Human Services, "Acute Pain Management: Operative or Medical Procedures and Trauma", U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 107~ (1993)
16. Pan Y, "Outcomes associated with clopidogrel-aspirin use in minor stroke or transient ischemic attack: a pooled analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) trials", JAMA Neurol, 76, pp.1466~1473 (2019)
17. Johnston SC, "Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA", N Engl J Med, 383, pp.207~217 (2020)
18. Jeong HG, "Stroke outcomes with use of antithrombotics within 24 hours after recanalization treatment", Neurology, 87, pp.996~1002 (2016)
19. Lee YS, "Cilostazol in Acute Ischemic Stroke Treatment(CAIST Trial) : a randomized double-blind non-inferiority trial", Cerebrovasc Dis, 32, pp.65~71 (2011)
20. Adams HP Jr, "Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)", Stroke, 39, pp.87~99 (2008)
21. Zhang S, "Safety of intra-arterial tirofiban administration in ischemic stroke patients after unsuccessful mechanical thrombectomy", J Vasc Interv Radiol, 30, pp.141~147 (2019)
22. Kim YW, "Local tirofiban infusion for remnant stenosis in large vessel occlusion : tirofiban ASSIST study", BMC Neurol, 20, pp.284~ (2020)
23. Baek BH, "Intravenous tirofiban infusion after angioplasty and stenting in intracranial atherosclerotic stenosis-related stroke", Stroke, 52, pp.1601~1608 (2021)
24. Saxena R, "Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial", Stroke, 32, pp.2333~2337 (2001)
25. Berge E, "Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial", Lancet, 355, pp.1205~1210 (2000)
26. Paciaroni M, "Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke : a meta-analysis of randomized controlled trials", Stroke, 38, pp.423~430 (2007)
27. Whiteley WN, "Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials", Lancet Neurol, 12, pp.539~545 (2013)
28. Giugliano RP, "Edoxaban versus warfarin in patients with atrial fibrillation", N Engl J Med, 369, pp.2093~2104 (2013)
29. Patel MR, "Rivaroxaban versus warfarin in nonvalvular atrial fibrillation", N Engl J Med, 365, pp.883~891 (2011)
30. Granger CB, "Apixaban versus warfarin in patients with atrial fibrillation", N Engl J Med, 365, pp.981~992 (2011)
31. Connolly SJ, "Dabigatran versus warfarin in patients with atrial fibrillation", N Engl J Med, 361, pp.1139~1151 (2009)
32. Paciaroni M, "Early recurrence and cerebral bleeding in patients with acute ischemic stroke and atrial fibrillation : effect of anticoagulation and its timing : the RAF Study", Stroke, 46, pp.2175~2182 (2015)
33. Arihiro S, "Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation : the SAMURAI-Nonvalvular Atrial Fibrillation(NVAF)study", Int J Stroke, 11, pp.565~574 (2016)
34. Seiffge DJ, "Early start of DOAC after ischemic stroke : risk of intracranial hemorrhage and recurrent events", Neurology, 87, pp.1856~1862 (2016)
35. Hong KS, "Rivaroxaban vs warfarin sodium in the ultra-early period after atrial fibrillation-related mild ischemic stroke : a randomized clinical trial", JAMA Neurol, 74, pp.1206~1215 (2017)
36. Wilson D, "Early versus late anticoagulation for ischaemic stroke associated with atrial fibrillation : multicentre cohort study", J Neurol Neurosurg Psychiatry, 90, pp.320~325 (2019)
37. Mizoguchi T, "Early initiation of direct oral anticoagulants after onset of stroke and short- and long-term outcomes of patients with nonvalvular atrial fibrillation", Stroke, 51, pp.883~891 (2020)
38. Brook RH, "A method for the detailed assessment of the appropriateness of medical technologies", Int J Technol Assess Health Care, 2, pp.53~63 (1986)
39. "Clinical research collaboration for stroke in Korea: CRCS-K statistics 2020 report" (2020)[URL]

관련 논문AI추천